Literature DB >> 9562663

Approach to peripheral neuropathy and neuronopathy.

R J Barohn1.   

Abstract

Neuropathic disorders encompass those that affect the neuron's cell body or neuropathies, those affecting the peripheral process, or peripheral neuropathies. The peripheral neuropathies can be broadly subdivided into the myelinopathies and axonopathies. These conditions can be hereditary or acquired. Each of these disorders has distinct clinical features that enable neurologists to recognize the various patterns of presentation. Once a particular pattern is established, further laboratory studies including electrophysiologic testing, nerve biopsy, and blood and cerebrospinal fluid examination can be performed to confirm the clinical impression. Therapy is available in some to correct the underlying disease state or at least to improve symptoms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562663     DOI: 10.1055/s-2008-1040857

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  14 in total

Review 1.  Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies.

Authors:  Kinga Szigeti; Eva Nelis; James R Lupski
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

2.  Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.

Authors:  Manoj Mittal; Mamatha Pasnoor; Reddiah B Mummaneni; Saud Khan; April McVey; David Saperstein; Laura Herbelin; Larry Ridings; Yunxia Wang; Mazen M Dimachkie; Richard J Barohn
Journal:  Int J Neurosci       Date:  2011-06-15       Impact factor: 2.292

3.  Cholecystokinin-8 enhances nerve growth factor synthesis and promotes recovery of capsaicin-induced sensory deficit.

Authors:  L Manni; T Lundeberg; P Tirassa; L Aloe
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

4.  Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases.

Authors:  D Lubec; W Müllbacher; J Finsterer; B Mamoli
Journal:  Postgrad Med J       Date:  1999-12       Impact factor: 2.401

5.  How well is peripheral neuropathy investigated? An audit from a regional neurophysiology department.

Authors:  S Murphy; B McNamara
Journal:  Ir J Med Sci       Date:  2006 Jan-Mar       Impact factor: 1.568

Review 6.  Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.

Authors:  Allyson J Ocean; Linda T Vahdat
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

7.  Chronic inflammatory demyelinating polyneuropathy.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

Review 8.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806

9.  Pattern-recognition approach to neuropathy and neuronopathy.

Authors:  Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2013-05       Impact factor: 3.806

Review 10.  Cryptogenic sensory polyneuropathy.

Authors:  Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2013-03-13       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.